SCN-16

N/A

Report date: 2022/01/11 18:01:15
NME

Base Information

Drug NameSCN-16
Drug Alias NameSCN-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
China Registration ClassN/A

Develop Information

Active CompaniesSecond Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A